We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

PET Imaging More Effective than Angiogram for Determining Need for Coronary Stents or Bypass Surgery

By HospiMedica International staff writers
Posted on 01 Dec 2022

Most forms of heart disease cause myocardial damage. Myocardial ischemia occurs when blood flow to the heart is reduced, preventing the heart muscle from receiving enough oxygen. When myocardial ischemia affects the deep, or subendocardial, layer of the left ventricular muscle, it is known as subendocardial ischemia. Subendocardial ischemia is commonly diagnosed in patients with cardiovascular disease, but it is not quantified by current imaging tools. The angiogram – an X-ray test that helps doctors evaluate blockages in the arterial system – shows how to do stents or bypass surgery, but not whether those procedures should be done at all.

Now, researchers at The University of Texas Health Science Center at Houston (Houston, TX, USA) have used positron emission tomography (PET) imaging technology to map coronary blood flow and its outcomes – namely, subendocardial ischemia – among patients with heart disease. The new method for determining whether patients with heart disease need coronary stents or bypass surgery is more effective than the angiogram, which is currently used, according to the researchers. The latest study confirmed the findings of their previous research by proving the PET threshold of severity at which stents and bypass surgery improve survival compared to medical treatment alone.


Image: PET imaging technology used to map coronary blood flow and its outcomes in heart disease patients (Photo courtesy of UTHealth Houston)
Image: PET imaging technology used to map coronary blood flow and its outcomes in heart disease patients (Photo courtesy of UTHealth Houston)

“The cumulative data reveals that all randomized trials of coronary stents and bypass surgery have failed to improve survival after revascularization due to profoundly flawed patient selection based on the angiogram,” said K. Lance Gould, MD, professor and the Martin Bucksbaum Distinguished University Chair in Heart Disease with McGovern Medical School at UTHealth Houston, who was first author on the study and led the team of researchers. “Thus, the coronary angiogram is not the gold standard for determining stents or bypass surgery, but rather, quantitative myocardial perfusion by PET is the gold standard.”

Related Links:
UTHealth Houston


Gold Member
12-Channel ECG
CM1200B
Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
Silver Member
Compact 14-Day Uninterrupted Holter ECG
NR-314P
New
Mechanical Baby Scale
seca 725

Latest Critical Care News

Machine Learning Tool Identifies Rare, Undiagnosed Immune Disorders from Patient EHRs

On-Skin Wearable Bioelectronic Device Paves Way for Intelligent Implants

First-Of-Its-Kind Dissolvable Stent to Improve Outcomes for Patients with Severe PAD